Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 34

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Signaling Pathways Involved on Alpha-1-Antitrypsin Mechanism of Action on Diabetic Retinopathy Treatment in ARPE-19 Cells

Juan E Gallo; Pablo Tate; MARÍA CONSTANZA POTILINSKI

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):285. doi:

ARVO Annual Meeting Abstract July 2019

Alpha-1 antitrypsin avoids epithelial to mesenchymal transition in ARPE-19 cells in a model of Diabetic Retinopathy

MARÍA CONSTANZA POTILINSKI; Juan Pablo Salica; Micaela Petrigliano; Eduardo Chuluyan; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5364. doi:

ARVO Annual Meeting Abstract July 2019

Alpha-1 Anti-trypsin Modulates Insulin Signaling in RPE cells in an in Vitro Model of Diabetic Retinopathy

Juan E Gallo; Micaela Petrigliano; Mariano Fernandez Acquier; Gustavo Ortiz; MARÍA CONSTANZA POTILINSKI

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5357. doi:

ARVO Annual Meeting Abstract July 2018

Alpha-1 Antitrypsin Decreases Cx43 Expression Through PI3K/AKT Pathway in ARPE-19 Cells Exposed to High Glycemia

MARÍA CONSTANZA POTILINSKI; Gustavo Ortiz; Juan Pablo Salica; Emiliano López; Eduardo Chuluyán; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):196. doi:

ARVO Annual Meeting Abstract July 2018

Alpha-1 Antitrypsin Decreases NFkB Signaling in Müller Cells in an in Vitro Diabetic Retinopathy Model.

Juan E Gallo; MARÍA CONSTANZA POTILINSKI; Gustavo Ortiz; Juan Pablo Salica; Emiliano López; Eduardo Chuluyán

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):201. doi:

ARVO Annual Meeting Abstract June 2017

Alpha-1-Anti-Trypsin increased Na + /K + -ATPase expression in an in vitro Müller cells diabetic retinopathy model

MARÍA CONSTANZA POTILINSKI; Gustavo Ortiz; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5200. doi:

ARVO Annual Meeting Abstract June 2017

Alpha-1-antitrypsin ameliorates features of oxidative stress and structural retinal damage in diabetic mice

Gustavo Ortiz; MARÍA CONSTANZA POTILINSKI; Juan Pablo Salica; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5201. doi:

ARVO Annual Meeting Abstract June 2017

ALPHA-1-ANTITRYPSIN REDUCE LEVELS OF TUMOR NECROSIS FACTOR ALPHA BOTH IN VITRO AND IN VIVO DIABETES MODELS.

Juan E Gallo; Gustavo Ortiz; MARÍA CONSTANZA POTILINSKI; Juan Pablo Salica; Emiliano S Lopez; Eduardo Chuluyan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5805. doi:

ARVO Annual Meeting Abstract September 2016

Muller cells treated with alpha 1 antitrypsin (AAT) in vitro showed less expression of VEGF and IL6

Gustavo Ortiz; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3236. doi:

ARVO Annual Meeting Abstract September 2016

Antiangiogenic Effect of a Novel Fusion Protein PFMC inhibiting NFKB pathway on Corneal Alkali Injury Rat Model

Juan Pablo Salica; Alejandro Fichetti; Eduardo Chuluyan; Diego Guerrieri; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3514. doi:

ARVO Annual Meeting Abstract September 2016

ALPHA-1 ANTITRYPSIN DIMINISHED ANGIOGENESIS IN HUMAN MICROVASCULAR CELLS EXPOSED TO HYPERGLYCEMIA.

Juan E Gallo; Gustavo Ortiz; Juan Pablo Salica; Eduardo Chuluyan

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4523. doi:

ARVO Annual Meeting Abstract June 2015

Alpha-1-Antitrypsin Reduced IL-6 mRNA Levels in Human Microvascular Cells Exposed to a High Amount of Glucose

Gustavo Ortiz; Jorge Mancini; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5180. doi:

ARVO Annual Meeting Abstract April 2014

The G-Protein Coupled Receptor P2Y2 is Upregulated in the Diabetic Rat Retina. Possible Role in Diabetic Retinopathy.

Juan E Gallo; Jorge Mancini; Gustavo Ortiz; Juan Croxatto; Nanomedicine & Vision Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1057. doi:

ARVO Annual Meeting Abstract April 2014

Antiinflammatory and antiangiogenic effect of a novel Fusion Protein “SLPI and Cementoin” targeting NF-κB pathway

Juan Pablo Salica; Eduardo Chuluyan; Diego Guerrieri; Gustavo Ortiz; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4725. doi:

ARVO Annual Meeting Abstract April 2014

Chronological analyses of the expression of A1AT in the retina of diabetic rats

Gustavo Ortiz; Jorge Mancini; Juan Pablo Salica; Eduardo Chuluyan; Juan E Gallo; Nanomedicine & Vision Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4914. doi:

ARVO Annual Meeting Abstract March 2012

Suramab Strongly Inhibits Neovascularization Through Downregulation of VEGF, FGF and P2X2 receptor

Emiliano S. Lopez; Juan O. Croxatto; Juan E. Gallo

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2400. doi:

ARVO Annual Meeting Abstract March 2012

Intravitreal Administration of FP-MC, Inhibitor of Nuclear Factor KB, Reduced Retinal Immunoreactivity of TNF-a, IL-17, c-PLA2, and GFAP in Type 1 Diabetic Rats

Juan P. Salica; Jorge E. Mancini; Eduardo Chuluyan; Paulo Maffia; Diego Guerrieri; Juan E. Gallo

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2794. doi:

ARVO Annual Meeting Abstract March 2012

Suramin and PPADS Downregulate Proinflammatory Citokines in the Retina of a Rat Model of Type 1 Diabetes

Juan E. Gallo; Jorge E. Mancini; Juan O. Croxatto

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3285. doi:

ARVO Annual Meeting Abstract April 2011

Effect Of Topical Administration Of Slpi And Fp-mc, Inhibitors Of Nuclear Factor K B, In Rats With Corneal Alkali Burns, 7 Days Post Injury

Juan P. Salica; Eduardo Chuluyan; Juan E. Gallo; Paulo Maffia; Diego Guerrieri; Andrés Rodriguez

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2029. doi:

ARVO Annual Meeting Abstract April 2011

Longitudinal Analysis Of Morphometrical Changes In The Retina Of Type 2 Diabetic Rats Fed On High-fat-diet

Jorge E. Mancini; J O. Croxatto; Juan E. Gallo

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5973. doi:

1 2

Next 20 Results »

Advertisement